Analyst Ratings for Valeant Pharmaceuticals International Inc. (VRX)Updated: 2017-07-26
An average rating of Hold has been given to Valeant Pharmaceuticals International Inc. (NYSE:VRX) by analysts covering the stock. A consensus rating of Hold was previously issued for VRX last month.
A buy rating was issued by 3 analysts, 1 gave an overweight rating, 13 gave a hold rating, 1 gave an underweight rating, and 4 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. During this time, the number of analysts bearish on the stock has increased by 0.
Many analysts weighed in on price targets for VRX. The highest price target was 35, which equates to a potential upside of 95.26 percent. The lowest price target was 8, implying a possible loss of -55.37 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0.53 percent. The average change in earnings estimates over the last 90 days is 0.54 percent. Meanwhile, fiscal year estimates have been revised downwards by -0.27 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -6.2 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. Over the same time period, 2 analysts revised their FY earnings estimates upwards, compared to 2 analysts that revised their FY estimates downwards.
In the trailing 52-weeks, VRX hit 32.75 at the highest peak, while it's lowest trading point was 8.31. Currently the stock is 115.7 percent higher than its low, and 45.27 percent below the high. VRX has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The VRX value stock report compares VRX to some of its peers using value stock charts. The stock has a market capitalization of $7.72 billion. VRX's next earnings release will be on 0000-00-00, which is days away.